Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Recommendation of “Buy” by Analysts

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has received a consensus rating of “Buy” from the fourteen research firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold r…

Read Full Article →